Yoga on our minds: a systematic review of yoga for neuropsychiatric disorders.
Yoga on our minds: a systematic review of yoga for neuropsychiatric disorders.
复制标题
DOI：
10.3389/fpsyt.2012.00117
复制
发表时间：
2012-01-01
影响因子：
4.7
通讯作者：
Doraiswamy, P Murali
中科院分区：
文献类型：
--
作者：
Balasubramaniam, Meera;Telles, Shirley;Doraiswamy, P Murali
背景：对临床上有效、安全、患者可接受且具有成本效益的精神疾病治疗形式的需求正在增长。几项研究已经证明瑜伽在特定的精神症状和一般意义上的well-being.Objective：为了系统地检查瑜伽在治疗选定的主要精神疾病的疗效的证据。电子检索对照试验的科克伦中心登记和标准书目数据库、MEDLINE、EMBASE和PsycINFO，2011年4月进行，2011年6月更新，使用关键词瑜伽和精神病学或抑郁或焦虑或精神分裂症或认知或记忆或注意力和随机对照试验（RCT）。研究瑜伽作为自变量和作为因变量的上述条款之一被纳入和排除criteria were applied.RESULTS：检索共得到124个试验，其中16个符合严格的标准，最终审查。B级证据支持瑜伽对抑郁症（4项RCT）、精神分裂症（3项RCT）、ADHD儿童（2项RCT）药物治疗的辅助治疗的潜在急性获益，C级证据支持睡眠投诉（3项RCT）。认知障碍和进食障碍的随机对照试验得出了相互矛盾的结果。没有研究着眼于一级预防，复发预防，或比较有效性与pharmacotherapy.CONCLUSION：有随机试验的证据，以支持流行的信念瑜伽抑郁症，睡眠障碍，并作为增强疗法。文献的局限性包括无法进行双盲研究、小型研究中的多重比较以及缺乏重复性。生物标志物和神经影像学研究，将瑜伽与标准药物和心理疗法进行比较的研究，以及长期疗效的研究，都需要充分转化瑜伽对增强心理健康的承诺。
BACKGROUND: The demand for clinically efficacious, safe, patient acceptable, and cost-effective forms of treatment for mental illness is growing. Several studies have demonstrated benefit from yoga in specific psychiatric symptoms and a general sense of well-being.OBJECTIVE: To systematically examine the evidence for efficacy of yoga in the treatment of selected major psychiatric disorders.METHODS: Electronic searches of The Cochrane Central Register of Controlled Trials and the standard bibliographic databases, MEDLINE, EMBASE, and PsycINFO, were performed through April 2011 and an updated in June 2011 using the keywords yoga AND psychiatry OR depression OR anxiety OR schizophrenia OR cognition OR memory OR attention AND randomized controlled trial (RCT). Studies with yoga as the independent variable and one of the above mentioned terms as the dependent variable were included and exclusion criteria were applied.RESULTS: The search yielded a total of 124 trials, of which 16 met rigorous criteria for the final review. Grade B evidence supporting a potential acute benefit for yoga exists in depression (four RCTs), as an adjunct to pharmacotherapy in schizophrenia (three RCTs), in children with ADHD (two RCTs), and Grade C evidence in sleep complaints (three RCTs). RCTs in cognitive disorders and eating disorders yielded conflicting results. No studies looked at primary prevention, relapse prevention, or comparative effectiveness versus pharmacotherapy.CONCLUSION: There is emerging evidence from randomized trials to support popular beliefs about yoga for depression, sleep disorders, and as an augmentation therapy. Limitations of literature include inability to do double-blind studies, multiplicity of comparisons within small studies, and lack of replication. Biomarker and neuroimaging studies, those comparing yoga with standard pharmaco- and psychotherapies, and studies of long-term efficacy are needed to fully translate the promise of yoga for enhancing mental health.